Pangcatan, Baby N.

HRN: 21-58-80  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/16/2022
07/22/2022
IV
60mg
Q24Hrs
PSNB
Waiting Final Action 
07/16/2022
AMPICILLIN 250MG (VIAL)
07/16/2022
07/22/2022
IV
200mg
Q12Hrs
PSNB
Waiting Final Action 
11/04/2022
AMPICILLIN 250MG (VIAL)
11/04/2022
11/10/2022
IV
215 Mg
Q6H
RAgt Positive COVID 19, Mild
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: